Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pediatrics/Neonatology | Genetic Disease
Phenylketonuria Clinical Trials
A listing of Phenylketonuria medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Los Angeles :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Orange :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Palo Alto :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
San Diego :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
San Francisco :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Colorado
Aurora : The Children's Hospital
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
Aurora :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
District of Columbia
Washington :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Florida
Gainesville : University of Florida
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
Gainesville :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Jacksonville :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Miami :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Tampa :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Georgia
Decatur :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Illinois
Chicago :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Indiana
Indianapolis :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Iowa
Iowa City :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Kansas
Wichita :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Kentucky
Louisville :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Louisiana
New Orleans :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Massachusetts
Boston : Children's Hospital Boston
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
Boston :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Minnesota
Minneapolis :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Missouri
Columbia :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Kansas City :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
St. Louis :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Nebraska
Omaha : Nebraska Medical Center
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
Omaha :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
New York
Albany : Albany Medical College
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
Albany :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Manhasset :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
New York :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Rochester :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
View More »
Valhalla :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
North Carolina
Chapel Hill :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Ohio
Akron :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Cincinnati :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Cleveland :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Columbus :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Oregon
Portland :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Pennsylvania
Hershey :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Philadelphia :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Pittsburgh :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Rhode Island
Providence :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
South Dakota
Sioux Falls :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Tennessee
Knoxville :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Texas
Houston :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Utah
Salt Lake City : University Utah
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
Salt Lake City :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Virginia
Charlottesville :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Norfolk :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Wisconsin
Madison :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Milwaukee :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Germany
Darmstadt : Please contact Merck KGaA Communication Center located in
Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Patients With Phenylketonuria
Puerto Rico
San Juan :
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
